About
Open menu
Leadership & Team
Board of Directors
Clinical Collaborations
Value Proposition
Technology
Open menu
Development Challenges
Groundbreaking Solution
Liquid Structure™ Technology
Investigational Drugs
Open menu
Nantheia™ A1002
Nantheia™ ATL5
Research and Development
Manufacturing
Supply Chain
Analytical Testing
Drug Master Files
Clinical Programs
Open menu
Pipeline
Clinical Trials
NYU PTSD
UNMC PTSD
UCLA Opioid Use
Mt. Sinai Phase I
NYU Social Anxiety
NYU Neuropathic Pain
Trial Infrastructure
Protocol Design & Development
Statistical Analysis
Trial Monitoring & Compliance
News
Open menu
Press Releases
News Archive
Contact Us
Open menu
Investigators
Investors
Media Contact
Menu
About
Open menu
Leadership & Team
Board of Directors
Clinical Collaborations
Value Proposition
Technology
Open menu
Development Challenges
Groundbreaking Solution
Liquid Structure™ Technology
Investigational Drugs
Open menu
Nantheia™ A1002
Nantheia™ ATL5
Research and Development
Manufacturing
Supply Chain
Analytical Testing
Drug Master Files
Clinical Programs
Open menu
Pipeline
Clinical Trials
NYU PTSD
UNMC PTSD
UCLA Opioid Use
Mt. Sinai Phase I
NYU Social Anxiety
NYU Neuropathic Pain
Trial Infrastructure
Protocol Design & Development
Statistical Analysis
Trial Monitoring & Compliance
News
Open menu
Press Releases
News Archive
Contact Us
Open menu
Investigators
Investors
Media Contact
OUR STORIES
Events Archive
2023 BofA Conference
March 8, 2024 at 6:32 AM
Click here for webcast
2023 Insert Event Name
March 8, 2024 at 6:31 AM
Click here for webcast
2023 Insert Event Name
March 8, 2024 at 6:31 AM
Click here for webcast
2023 Insert Event Name
March 8, 2024 at 6:16 AM
Click here for webcast
Presentations
March 8, 2024
Corporate Overview
March 8, 2024
Lorem Ipsum Dolor Mit
March 8, 2024
Lorem Ipsum Dolor Mit
March 8, 2024
3Q23 Earnings Presentation
Press Releases
News Archive
Press Releases
News Archive
“
What sets Ananda Scientific apart is our commitment to creating medicines that address unmet therapeutic needs.
